First entirely AI developed drug green lit for clinical trial
A drug candidate for obsessive-compulsive disorder will enter clinical trials, after being discovered and readied in under 12 months.
A drug candidate for obsessive-compulsive disorder will enter clinical trials, after being discovered and readied in under 12 months.
Noscendo builds on its diagnostic platform to enable identification of antibiotic resistant microorganisms, in partnership with German hospital.
Both major pharma companies have used January to announce programs to reduce their climate impact.
Accenture’s Intient platform for clinical data management will use Google Cloud as a cloud technology provider.